AZ spearheads cancer funding plan

AstraZeneca is spearheading the push for the establishment of an Australian Interim Cancer Fund (ICF) to expedite access to innovative treatments for cancer patients, with a Roundtable to discuss the initiative being held today in Canberra.

Under the plan, medicines would be funded after TGA approval while further data is being collected to support reimbursement through the PBS.

Chair of the House of Reps Standing Committee on Health, Aged Care and Sport, Dr Mike Freelander, and his Deputy, Melissa McIntosh, will host the Roundtable at Parliament House with more than 30 oncology leaders and MPs in attendance.